JPRN-UMIN000001820未知2 期
Single Arm Phase II Trial of Nitroglycerin Plus Docetaxel in Elderly Untreated Stage IIIB/IV Non-small-cell Lung Cancer - Single Arm Phase II Trial of Nitroglycerin Plus Docetaxel in Elderly Untreated Stage IIIB/IV Non-small-cell Lung Cancer (TUTRCDC003)
Tohoku University Translational Research Center0 个研究点目标入组 40 人开始时间: 2009年3月31日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(a)No treatment with a vasodilator such as calcium channel blockers (b)No prior chemotherapy or radiotherapy; (c)Without uncontrollable brain metastasis; (d)No ischemic heart disease; (e)Without active interstitial pneumonitis (f)Without uncontrollable massive pleural effusion or pericardial effusion (g)Without pregnancy or nurse (h)No enrollment in another interventional study
研究者
相似试验
已完成
2 期
efficacy of intravenous nitroglycerine infusion in the prevention of arterial spasm in transradial coronary angiographyIRCT20160515027905N2Iran University of Medical Sciences100
进行中（未招募）
1 期
Multinational, multicenter, phase 2 study of the efficacy and safety of ABY-035 in treating and preventing relapse/recurrence of disease activity in subjects with non-infectious intermediate, posterior or pan-uveitis.non-infectious intermediate, posterior, or pan-uveitisMedDRA version: 20.0Level: PTClassification code 10046851Term: UveitisSystem Organ Class: 10015919 - Eye disordersEUCTR2020-004964-25-ITAffibody AB110
进行中（未招募）
1 期
Multinational, multicenter, phase 2 study of the efficacy and safety of ABY-035 in treating and preventing relapse/recurrence of disease activity in subjects with non-infectious intermediate, posterior or pan-uveitis.non-infectious intermediate, posterior, or pan-uveitisMedDRA version: 20.0Level: PTClassification code 10046851Term: UveitisSystem Organ Class: 10015919 - Eye disordersEUCTR2020-004964-25-ESAffibody AB110
进行中（未招募）
1 期
Multinational, multicenter, phase 2 study of the efficacy and safety of ABY-035 in treating and preventing relapse/recurrence of disease activity in subjects with non-infectious intermediate, posterior or pan-uveitis.non-infectious intermediate, posterior, or pan-uveitisMedDRA version: 20.0Level: PTClassification code 10046851Term: UveitisSystem Organ Class: 10015919 - Eye disordersEUCTR2020-004964-25-DEAffibody AB20
尚未招募
3 期
STUDY OF SUBCUTANEOUS NITROGLYCERINE INFILTRATION FOR TRANS-RADIAL ACCESS IN IMPROVING THE SUCCESS RATE AND REDUCING EARLY RADIAL ARTERY BLOCKAGECTRI/2024/07/070635JN Medical College AMU Aligarh